Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | President, International | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 64,744 |
Ending reported balance
After 2026-09-02 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-09-01 · Exercise / conversion · Acquired 4,556 · Balance 62,227 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2026-09-01 · Exercise / conversion · Acquired 8,717 · Balance 70,944 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 3 · 2026-09-02 · Sale · Disposed 6,200 · Balance 64,744 F2: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,114 |
Reported balance
After 2026-09-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-01 · Exercise / conversion · Disposed 4,556 · Balance 9,114 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3: On March 19, 2024, the reporting person was granted 54,675 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 52,302 |
Reported balance
After 2026-09-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-01 · Exercise / conversion · Disposed 8,717 · Balance 52,302 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4: On March 1, 2025, the reporting person was granted 104,602 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3: On March 19, 2024, the reporting person was granted 54,675 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
F4: On March 1, 2025, the reporting person was granted 104,602 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2025 Filed Mar 4, 2025 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,100 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000018 · wk-form4_1741122388.xml · nonDerivative · entry 2 Nueno Carlos · CIK 0002037711 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,123 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000018 · wk-form4_1741122388.xml · nonDerivative · entry 1 Nueno Carlos · CIK 0002037711 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,123 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| December 03, 2024 Filed Dec 3, 2024 22:30 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,890 | $11.23 | $32,454.70 |
DisclosureSEC source: 0001628280-24-049800 · wk-form4_1733265001.xml · nonDerivative · entry 5 Nueno Carlos · CIK 0002037711 · President, International 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F4 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 6, 2023. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 22:30 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,389 | $11.93 | $28,493.60 |
DisclosureSEC source: 0001628280-24-049800 · wk-form4_1733265001.xml · nonDerivative · entry 4 Nueno Carlos · CIK 0002037711 · President, International 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,890 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:30 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-049800 · wk-form4_1733265001.xml · derivative · entry 8 Nueno Carlos · CIK 0002037711 · President, International 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,502 Underlying: Common Stock · 3,100 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis F7 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F7 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:30 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-049800 · wk-form4_1733265001.xml · derivative · entry 7 Nueno Carlos · CIK 0002037711 · President, International 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,123 Underlying: Common Stock · 1,123 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis F6 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 13,475 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 13,475 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:30 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,056 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-049800 · wk-form4_1733265001.xml · derivative · entry 6 Nueno Carlos · CIK 0002037711 · President, International 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,285 Underlying: Common Stock · 1,056 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:30 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,100 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-049800 · wk-form4_1733265001.xml · nonDerivative · entry 3 Nueno Carlos · CIK 0002037711 · President, International 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,279 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:30 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,123 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-049800 · wk-form4_1733265001.xml · nonDerivative · entry 2 Nueno Carlos · CIK 0002037711 · President, International 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:30 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,056 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-049800 · wk-form4_1733265001.xml · nonDerivative · entry 1 Nueno Carlos · CIK 0002037711 · President, International 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.